HWM
AXNX

HighMark Wealth Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

HighMark Wealth Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-175
Closed -$12.2K – 630
2024
Q3 		$12.2K Hold
175
– – 0.01% 262
2024
Q2 		$11.8K Sell
175
-350
-67% -$23.6K 0.01% 256
2024
Q1 		$36.2K Hold
525
– – 0.02% 159
2023
Q4 		$32.7K Hold
525
– – 0.02% 158
2023
Q3 		$29.5K Buy
525
+350
+200% +$19.7K 0.02% 146
2023
Q2 		$8.83K Hold
175
– – 0.01% 274
2023
Q1 		$9.55K Hold
175
– – 0.01% 300
2022
Q4 		$10.9K Hold
175
– – 0.01% 239
2022
Q3 		$12K Hold
175
– – 0.01% 227
2022
Q2 		$10K Hold
175
– – 0.01% 255
2022
Q1 		$11K Hold
175
– – 0.01% 256
2021
Q4 		$10K Sell
175
-288
-62% -$17.6K 0.01% 264
2021
Q3 		$30K Buy
463
+40
+9% +$2.73K 0.02% 150
2021
Q2 		$27K Buy
423
+35
+9% +$2.07K 0.02% 164
2021
Q1 		$23K Buy
+388
New +$21.1K 0.02% 159

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HighMark Wealth Management's AXNX Position: Q4 2024 in Review

HighMark Wealth Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 175 shares — an estimated $12.2K sold.

HighMark Wealth Management first reported a position in AXNX in Q1 2021 and held it in 15 quarters. The position peaked at $36.2K in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • HighMark Wealth Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • HighMark Wealth Management sold 175 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $12.2K.
  • HighMark Wealth Management first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
  • HighMark Wealth Management's Axonics, Inc. Common Stock position peaked at $36.2K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on HighMark Wealth Management's 13F filing for Q4 2024, filed 31 Jan 2025.